KIDNEY TRANSPLANT INFECTION
Clinical trials for KIDNEY TRANSPLANT INFECTION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT INFECTION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kidney transplant patients battling BK virus
Disease control Recruiting nowThis study tests two drug combinations to treat BK virus infection in kidney transplant recipients. BK virus can damage the new kidney, and current treatment is limited to lowering immune-suppressing drugs. The trial compares everolimus plus reduced tacrolimus versus reduced tacr…
Matched conditions: KIDNEY TRANSPLANT INFECTION
Phase: NA • Sponsor: King Chulalongkorn Memorial Hospital • Aim: Disease control
Last updated May 26, 2026 05:58 UTC
-
Can a simple infusion save transplanted kidneys from a common virus?
Disease control Recruiting nowThis study tests whether reducing anti-rejection drugs and adding an intravenous immunoglobulin (IVIG) infusion can better control BK virus infection in kidney or kidney-pancreas transplant patients. About 280 participants will be randomly assigned to receive either standard care…
Matched conditions: KIDNEY TRANSPLANT INFECTION
Phase: PHASE3 • Sponsor: The University of Queensland • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Immune-Guided strategy could reduce CMV infections in kidney transplants
Disease control Recruiting nowThis study compares two ways to prevent cytomegalovirus (CMV) infection in kidney transplant patients who already carry the virus. One approach gives antiviral drugs to everyone for three months, while the other uses immune system tests to decide who needs treatment. The goal is …
Matched conditions: KIDNEY TRANSPLANT INFECTION
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
New approach could reduce harsh drug side effects for transplant patients fighting CMV
Disease control Recruiting nowThis study is testing whether a drug called letermovir can prevent cytomegalovirus (CMV) infections from coming back in high-risk kidney or kidney/pancreas transplant patients. Researchers want to see if switching to letermovir earlier than usual can reduce the time patients need…
Matched conditions: KIDNEY TRANSPLANT INFECTION
Phase: PHASE3 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Apr 15, 2026 16:16 UTC